有两处:


所有跟贴·加跟贴·新语丝读书论坛

送交者: 羽矢 于 2010-11-07, 10:50:42:

回答: 感觉公开信稿件太长、太杂,试着给砍了一些 由 eddie 于 2010-11-07, 09:12:25:

第一处:
引用:
4. Independent experts both inside and outside of China are able to attribute some patients' voiding ability to intra-abodminal pressure rather than the detrusor contraction.

=>

4. Independent experts both inside and outside of China are able to attribute some patients' voiding to intra-abodminal pressure rather than the detrusor contraction, and the effects of Xiao's procedure are actually that of the closely related conventional treatments of neurogenic bladders - denervation and/or detethering, instead of reinervation of the procedure itself [].

第二处:
[quote]They have also exaggerated the number of patients of the NIH sponsored trial at New York University in their publication [] and news release []
[/quote]
"They" are doctors in Germany, and doctors at ACH

[quote]Blount JP and Tuite G. Xiao Procedure. Pediatric ShortCuts Newsletter. Spring 2009
http://www.neurosurgery.org/xiaoS09.asp
The National Institutes of Health sponsored a trial for 40 spinal-cord-injured patients at New York University in 2003. An 80 percent response rate was reported.
[Note] Dr. Tuite is one of the neurosurgeons who lead the clinical trial at All Children’s Hospital in Fla., see:
http://www.wctv.tv/medicalminute/interviewheadlines/47870982.html

News release of the University of Tuebingen
http://www.uni-protokolle.de/nachrichten/id/105332/
13 Patienten wurden bisher in den USA versorgt und wiesen eine deutlich schnellere Regeneration der Blasenfunktion von sechs Monaten auf, mit einer annahernd gleich bleibenden Erfolgswahrscheinlichkeit von 80 Prozent.
English translation:
So far, 13 patients had been treated in the U.S. and it showed a noticeably fast recovery of bladder function from six months, with an almost the same constant 80% success rate (as Dr. Xiao previously reported).
[Note] According to Dr. Xiao's presentation at SIU 2009, among 6 SCI patients at the University of Tuebingen, "only 2 showed some improvement". Dr. Karl-Dietrich Sievert is one of doctors who led the clinical trial. He is one of the signees of the Open letter in support of Chuan-Guo Xiao. He is also the author of the Editorial Comment on Xiao's 2006 review.
[/quote]




所有跟贴:


加跟贴

笔名: 密码: 注册笔名请按这里

标题:

内容: (BBCode使用说明